In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Dr. Reddy's acquires eight US ANDAs from Teva

Executive Summary

Dr. Reddy's Laboratories Ltd. acquired a portfolio of eight Abbreviated New Drug Applications in the US from Teva Pharmaceutical Industries Ltd. for $350mm in cash. The products include buprenorphine/naloxone sublingual film, ethinyl estradiol/etonogestrel vaginal ring, ezetimibe/simvastatin tablets, metformin/saxagliptin ER tablets, tobramycin inhalation solution, phentermine/topiramate ER capsules, imiquimod topical cream, and ramelteon tablets.

Deal Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Generic Drugs
    • OTC, Consumer
Deal Status
  • Final
Deal Type
  • Alliance
    • Marketing (Licensing)
    • Product Purchase

Related Companies